Clinical Trial Site

Milwaukee, Wisconsin 53226

2 studies enrolling now · 6 studies all time

What they study most

AQP4+ NMOSD, Breast Cancer, ER Positive Breast Cancer, Generalized Myasthenia Gravis, HER2 Negative Breast Carcinoma, Hearing Loss, Sensorineural, Hereditary Transthyretin-mediated (ATTRv) Amyloidosis, Locally Advanced Breast Cancer, Metastatic Breast Cancer, NMOSD, Neuromyelitis Optica Spectrum Disorder, Noise Induced Hearing Loss

Studies at this site

• Palazestrant in Combination With Ribociclib for the First-line Treatment of ER+/HER2- Advanced Breast Cancer — Recruiting now
• Registry of Patients With AQP4+ NMOSD Treated With Alexion C5 Inhibitor Therapies — Recruiting now
• Registry of Participants With Generalized Myasthenia Gravis Treated With Alexion C5 Inhibition Therapies (C5ITs) — Recruiting now
• FX-322 in Adults With Acquired Sensorineural Hearing Loss — Completed
• A Study of Ravulizumab (ALXN1210) in Children and Adolescents With Paroxysmal Nocturnal Hemoglobinuria — Completed
• A Multicenter Observational Study to Evaluate the Effectiveness of Patisiran in Patients With Polyneuropathy of ATTRv Amyloidosis With a V122I or T60A Mutation — Completed